These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38218980)

  • 1. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.
    Moon KJ; Whitehead HD; Trinh A; Hasenstab KA; Hayes KL; Stanley D; Carter B; Barclay R; Lieberman M; Nawaz S
    Harm Reduct J; 2024 Jan; 21(1):11. PubMed ID: 38218980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
    Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
    Glick JL; Christensen T; Park JN; McKenzie M; Green TC; Sherman SG
    Drug Alcohol Depend; 2019 Jan; 194():527-532. PubMed ID: 30551090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative assessment of key considerations for drug checking service implementation.
    Grace Rose C; Pickard AS; Kulbokas V; Hoferka S; Friedman K; Epstein J; Lee TA
    Harm Reduct J; 2023 Oct; 20(1):151. PubMed ID: 37848875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
    Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
    Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
    Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C; Matsumoto A; Boulad M; Stopka TJ
    Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
    [No Abstract]   [Full Text] [Related]  

  • 16. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
    Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
    Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
    Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
    Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.